Hiii,.I've just started surgery posting today
Hemorrhage and shock 101 please
| Type | Mechanism | Classic Example | Key Feature |
|---|---|---|---|
| Hypovolemic | ↓ intravascular volume | Trauma, GI bleed, burns | Cold, clammy, tachycardic |
| Distributive | ↓ SVR / vasodilation | Sepsis, anaphylaxis, neurogenic | Warm skin (early sepsis) |
| Cardiogenic | Pump failure | MI, myocarditis | Pulmonary edema |
| Obstructive | Outflow obstruction | Tension pneumo, tamponade, PE | Raised JVP |
In surgery, hypovolemic (hemorrhagic) shock is what you'll encounter most — especially in trauma and post-op patients.

| Class | Blood Loss | HR | BP | Urine Output | Mental Status | Treatment |
|---|---|---|---|---|---|---|
| I | <15% (<750 mL) | <100 | Normal | >30 mL/h | Normal | IV fluids |
| II | 15–30% (750–1500 mL) | >100 | ↓ | 20–30 mL/h | Anxious | IV fluids |
| III | 30–40% (1500–2000 mL) | >120 | ↓↓ | 5–15 mL/h | Confused | Fluids + blood |
| IV | >40% (>2000 mL) | >140 | ↓↓↓ | Negligible | Lethargic/unconscious | Fluids + blood (emergency) |
⚠️ The goal is to catch shock at Stage 1 or 2 — never let it reach Stage 3.
Hypothermia + Acidosis + Coagulopathy — each worsens the others. Breaking this cycle is the core of damage control surgery.
Shock = ↓ O₂ delivery to tissues
Hemorrhagic shock = most common in surgery
Signs: tachycardia > hypotension (BP is a late sign!)
ATLS Class I→IV based on blood loss %
3 stages: Compensated → Decompensated → Irreversible
Treatment: Stop bleeding + Fluids + Blood products + Monitor UO
Avoid: Lethal triad (hypothermia + acidosis + coagulopathy)
General Examination and specific thyroid Examination
thyroid goiter examination neck swelling
Graves disease exophthalmos proptosis hyperthyroidism clinical signs
| Parameter | What to Look For |
|---|---|
| Build & Nutrition | Obese / average / thin / cachectic / wasted |
| Pallor | Conjunctival pallor (pull lower lid) → anaemia |
| Jaundice | Sclerae (yellow tinge) → liver/haemolysis |
| Cyanosis | Central (tongue) or peripheral (fingertips) |
| Clubbing | Grades 1–4; causes: lung, heart, liver, IBD |
| Lymphadenopathy | Cervical, axillary, inguinal nodes |
| Oedema | Pitting (press shin for 5s) vs non-pitting |
| Dehydration | Skin turgor (pinch abdomen), dry tongue, sunken eyes |
| Pulse | Rate, rhythm, volume, character |
| Temperature | Febrile / afebrile |
Surgery tip: Always add vitals (BP, HR, RR, SpO₂, temp) and urine output in surgical patients.
"The patient is conscious, oriented, and cooperative. She is moderately built and nourished. She has no pallor, jaundice, cyanosis, or clubbing. There is no significant lymphadenopathy or pedal oedema."
Ask the patient to swallow while you watch the neck from across the room. A thyroid swelling moves up with swallowing — this distinguishes it from other neck lumps. A thyroglossal cyst moves up with tongue protrusion.

| Test | How | Positive = |
|---|---|---|
| Kocher's test | Press laterally on the goitre | Stridor → tracheal compression |
| Pemberton's sign | Ask patient to raise both arms above head | Facial plethora, JVP rise, cyanosis → retrosternal goitre compressing superior vena cava |
| Berry's sign | Palpate carotid pulse medially | Absent pulsation on one side → malignant infiltration |
Pemberton's sign is one of those dramatic signs you'll love showing on rounds.

| System | Signs |
|---|---|
| Hands | Fine tremor (paper test), warm moist palms, thyroid acropathy (clubbing), onycholysis (Plummer's nails) |
| Pulse | Tachycardia, irregularly irregular (AF) |
| Eyes | Exophthalmos, lid lag (von Graefe's sign), lid retraction (Dalrymple's sign), chemosis, ophthalmoplegia |
| Skin | Pretibial myxedema (non-pitting, over shins), hyperpigmentation |
| Reflexes | Hyperreflexia |
| System | Signs |
|---|---|
| Hands | Cold dry skin, nail brittleness |
| Face | Puffy, myxedematous face, loss of lateral eyebrow (Queen Anne's sign) |
| Hair | Dry, brittle, thinning; loss of outer third of eyebrows |
| Voice | Hoarse |
| Reflexes | Slow-relaxing reflexes (hung-up reflex) — a classic sign! |
| Pulse | Bradycardia |
"On inspection, there is a diffuse smooth swelling in the anterior neck involving both lobes of the thyroid, which moves up with deglutition. On palpation from behind, the gland is diffusely enlarged, smooth, non-tender, firm, mobile, not fixed to skin or deep structures. Trachea is central. No cervical lymphadenopathy is palpable. On percussion, there is no retrosternal dullness. On auscultation, a bruit is present over both lobes. General examination reveals fine tremors, warm moist hands, and lid lag — consistent with hyperthyroidism."
Thyroid swelling moves UP with swallowing ← key differentiator
Palpate from BEHIND (surgeon's approach)
Hard + fixed + LN → think malignancy
Bruit → Graves' disease (hyperthyroid)
Pemberton's sign → retrosternal extension
Tremor + tachycardia + exophthalmos → Graves' triad
Slow reflexes + puffy face + bradycardia → Hypothyroid
Inguinal hernia 101
Hernias 101
Thyroid ca 101
papillary thyroid carcinoma histology microscopy Orphan Annie eye nuclei
Papillary → Follicular → Medullary → Anaplastic
| Feature | Papillary | Follicular | Medullary | Anaplastic |
|---|---|---|---|---|
| Frequency | ~85% | 5–15% | <5% | ~1% |
| Cell of origin | Follicular cell | Follicular cell | C cells (parafollicular) | Follicular cell |
| Spread | Lymphatics | Blood (lungs, bone, liver) | Lymphatics + blood | Local invasion + blood |
| Marker | Thyroglobulin | Thyroglobulin | Calcitonin | None |
| Key mutation | BRAF V600E, RET fusion | RAS, PAX8/PPARG | RET point mutation | TP53 loss |
| Prognosis | Excellent (>95% 10-yr survival) | Good (minimally invasive) to moderate | Intermediate | Uniformly lethal |
| Radioiodine (RAI) sensitive? | Yes | Yes | No | No |

Key point: The nuclear features alone are diagnostic even WITHOUT papillary architecture.
Surgeon's pearl: FNAC says "follicular lesion" → operate, because you cannot distinguish adenoma from carcinoma without the surgical specimen.
| Syndrome | Components |
|---|---|
| MEN 2A | MTC + Phaeochromocytoma + Hyperparathyroidism |
| MEN 2B | MTC + Phaeochromocytoma + Mucosal neuromas + Marfanoid habitus |
| Familial MTC | MTC only (germline RET, no other MEN features) |
Any patient with MTC should be screened for phaeochromocytoma before surgery — operating on an undiagnosed phaco can kill the patient.

Step 1: TSH (is it hyper/hypo/euthyroid?)
Step 2: Ultrasound (USS) — size, echogenicity, margins, calcifications, LN
Step 3: FNAC (fine needle aspiration cytology) → Bethesda system reporting
Step 4: If follicular lesion on FNAC → surgery (hemithyroidectomy)
Step 5: CT neck/chest if large, substernal, or suspected malignancy
Step 6: Calcitonin if MTC suspected
Step 7: Thyroglobulin post-thyroidectomy for follow-up
| Bethesda Category | Diagnosis | Malignancy Risk | Action |
|---|---|---|---|
| I | Non-diagnostic | — | Repeat FNAC |
| II | Benign | <3% | Observe |
| III | Atypia of undetermined significance | ~10–30% | Repeat / molecular testing |
| IV | Follicular neoplasm | 25–40% | Hemithyroidectomy |
| V | Suspicious for malignancy | 60–75% | Surgery |
| VI | Malignant | >97% | Surgery |
| Type | Surgery | Radioiodine (¹³¹I) | TSH Suppression | Monitoring |
|---|---|---|---|---|
| Papillary | Total thyroidectomy ± neck dissection | Yes (if high risk) | Yes | Thyroglobulin + USS |
| Follicular | Total thyroidectomy | Yes | Yes | Thyroglobulin + USS |
| Medullary | Total thyroid + central neck dissection | No | No | Calcitonin |
| Anaplastic | Palliative surgery/tracheostomy | No | No | CT imaging |
✗ Hard, firm, fixed, non-tender thyroid nodule
✗ Rapid growth
✗ Hoarseness (recurrent laryngeal nerve invasion)
✗ Dysphagia (oesophageal invasion)
✗ Cervical lymphadenopathy
✗ History of neck radiation
✗ Age extremes (<20 or >60)
✗ Male sex (more likely malignant than in females)
✗ Family history of MTC or MEN
4 types: Papillary (85%) > Follicular > Medullary > Anaplastic
PTC: Orphan Annie nuclei + psammoma bodies, lymphatic spread, excellent prognosis
Follicular: Cannot diagnose by FNAC alone, haematogenous spread
Medullary: C cells, calcitonin marker, amyloid on histo, RET mutation, MEN2
Anaplastic: Rapidly enlarging hard mass, TP53 loss, uniformly lethal
Work-up: USS → FNAC (Bethesda) → Surgery
Radioiodine works: PTC and FTC only
Acute cholecystitis
Urology : Neoplasms of kidney, ureter, & bladder 101
Do surgery operation 101
| Investigation | Why |
|---|---|
| FBC | Anaemia, infection, platelets |
| RFT (Urea, Creatinine, Electrolytes) | Renal function, K+ (risk with anaesthesia) |
| LFT | Clotting factors, nutritional status |
| Coagulation (PT/INR, aPTT) | Bleeding risk |
| Blood group & cross-match | Anticipate transfusion |
| ECG | Cardiac baseline (>40 yrs or cardiac hx) |
| CXR | Baseline, detect pulmonary pathology |
| Blood glucose / HbA1c | Diabetics — perioperative glucose control |
| Grade | Description | Example |
|---|---|---|
| ASA I | Healthy | Young fit patient |
| ASA II | Mild systemic disease | Controlled DM, HTN |
| ASA III | Severe systemic disease | Poorly controlled DM, COPD |
| ASA IV | Life-threatening disease | Recent MI, severe heart failure |
| ASA V | Moribund | Ruptured AAA |
| ASA VI | Brain-dead donor | Organ harvest |
Higher ASA = higher anaesthetic and operative risk. Surgeons quote this when consenting patients.
| What | Time before surgery |
|---|---|
| Clear fluids | 2 hours |
| Breast milk | 4 hours |
| Solids / formula / non-clear fluids | 6 hours |
| Mnemonic: 2-4-6 rule |
| Pause | When | What's checked |
|---|---|---|
| Sign In | Before anaesthesia | Identity, consent, site marked, allergies, anaesthetic check |
| Time Out | Before skin incision | Team introductions, procedure confirmed, antibiotics given, imaging displayed |
| Sign Out | Before patient leaves OT | Instrument/swab counts correct, specimen labelled, post-op plan |
| Type | What it is | Example |
|---|---|---|
| General (GA) | Patient fully unconscious | Laparotomy, thoracotomy |
| Regional — Spinal | Intrathecal injection → lower body block | LSCS, lower limb surgery |
| Regional — Epidural | Epidural space → continuous block | Labour analgesia, major abdominal |
| Regional — Nerve block | Block a specific nerve | Axillary block for hand surgery |
| Local | Infiltrate operative site | Minor procedures, biopsies |
| Sedation (MAC) | Monitored, patient conscious | Endoscopy, minor procedures |
Hypnosis (unconscious) + Analgesia (pain-free) + Muscle relaxation (still)
| Instrument | Use |
|---|---|
| Scalpel | Skin incision (10 blade most common, 15 for fine work) |
| Dissecting forceps (tissue/non-toothed) | Hold/manipulate tissue |
| Artery forceps (haemostat) — Kocher, Spencer-Wells | Clamp vessels |
| Allis forceps | Grasp tissue firmly |
| Needle holder (Mayo-Hegar) | Hold suture needle |
| Metzenbaum scissors | Dissect delicate tissue |
| Mayo scissors | Cut sutures, tougher tissue |
| Retractors — Deaver, Langenbeck, Balfour | Expose operative field |
| Diathermy (electrocautery) | Cutting + coagulation (monopolar/bipolar) |
| Suction — Yankauer, Poole | Clear blood/fluid |
| Absorbable | Non-absorbable |
|---|---|
| Vicryl (polyglactin) | Prolene (polypropylene) |
| Monocryl | Nylon (Ethilon) |
| PDS | Silk |
| Gut (plain/chromic) | Steel wire |
1. Vitals: every 15 min x 4, then hourly x 4, then 4-hourly
2. IV fluids: type, rate
3. Medications: analgesics, antibiotics, antiemetics, DVT prophylaxis
4. NBM or diet order (when to start feeding)
5. Drain: monitor output, when to remove
6. Catheter: monitor urine output (>0.5 mL/kg/hr)
7. Wound: dressing instructions
8. Special orders: blood glucose monitoring, O₂, positioning
| Day | "W" | Cause |
|---|---|---|
| Day 1–2 | Wind | Atelectasis (collapsed lung segments) |
| Day 3–5 | Water | UTI (urinary tract infection) |
| Day 3–5 | Wound | Wound infection |
| Day 5–7 | Walking | DVT / PE |
| Day 7+ | Wonder drugs | Drug fever / abscess / anastomotic leak |
| Position | Used for |
|---|---|
| Supine | Laparotomy, hernia repair, appendicectomy |
| Lithotomy | Perianal/rectal surgery, gynaecology, TURP |
| Trendelenburg | Pelvic surgery, laparoscopy (bowel falls away from pelvis) |
| Reverse Trendelenburg | Upper abdominal/laparoscopic cholecystectomy |
| Lateral decubitus | Thoracotomy, nephrectomy |
| Prone | Posterior spinal surgery, pilonidal sinus |
| Sitting (beach chair) | Shoulder surgery |
Pre-op: History + Ix → ASA grading → Consent → NBM 2-4-6 → Mark site
In OT: WHO checklist → Anaesthesia triad → Sterile field → Instruments
Sutures: Absorbable (deep) vs Non-absorbable (skin/vascular)
Post-op: Monitor vitals/drains/UO → 5 Ws for fever → Mobilise early
Antibiotics: Give WITHIN 60 mins before incision
DVT: TED stockings + LMWH + mobilise
Basic surgery 10
On operative surgery
if the patient vomited fresh blood and malena with liver cirrhosis
Thyroid ca 101
| Type | Frequency | Origin | Key Feature | Spread | Prognosis |
|---|---|---|---|---|---|
| Papillary | ~85% | Follicular cell | Orphan Annie nuclei + psammoma bodies | Lymphatics | Excellent (>95% 10-yr) |
| Follicular | 5–15% | Follicular cell | Can't diagnose by FNAC alone | Blood (lung, bone) | Good–moderate |
| Medullary | <5% | C cells | Calcitonin marker + amyloid | Lymph + blood | Intermediate |
| Anaplastic | ~1% | Follicular cell (dedifferentiated) | Rapidly enlarging hard mass | Local + blood | Uniformly lethal |
TSH → USS → FNAC (Bethesda I–VI) → Surgery if needed
Hard + fixed nodule | Rapid growth | Hoarseness
Cervical LN | Neck radiation history | Male sex
Age <20 or >60 | Family history of MTC/MEN
| Cancer | Marker | Method |
|---|---|---|
| PTC / FTC | Thyroglobulin + USS | Serial monitoring |
| MTC | Calcitonin | Serial monitoring |
Make a comparison table of thyroid cancer types
| Feature | Papillary | Follicular | Medullary | Anaplastic |
|---|---|---|---|---|
| Frequency | ~85% | 5–15% | <5% | ~1% |
| Cell of origin | Follicular epithelium | Follicular epithelium | Parafollicular C cells | Follicular epithelium (dedifferentiated) |
| Age group | 30–50 yrs | 40–60 yrs | 40–50 yrs (sporadic) | >60 yrs |
| Sex predilection | F > M | F > M (3:1) | F = M | F > M |
| Associated conditions | Radiation exposure, Hashimoto's | Iodine deficiency | MEN 2A, MEN 2B, Familial MTC | Pre-existing PTC/follicular |
| Key mutation | BRAF V600E (~80%), RET fusion | RAS, PAX8/PPARG fusion | RET point mutation (germline + somatic) | TP53 loss |
| Gross appearance | Solid/cystic, may be multifocal | Single nodule, well-circumscribed | Firm, pale-grey, no capsule | Bulky, infiltrative, necrotic |
| Histology hallmarks | Orphan Annie nuclei, nuclear grooves, pseudo-inclusions, psammoma bodies, papillary fronds | Well-formed follicles resembling normal thyroid; diagnosis by capsular/vascular invasion | Polygonal-spindle cells in nests; amyloid in stroma; neuroendocrine granules | Pleomorphic/giant cells, spindle cells, no differentiation |
| Psammoma bodies | Yes (pathognomonic) | No | No | No |
| Amyloid stroma | No | No | Yes | No |
| FNAC diagnosis | Yes — nuclear features diagnostic | No — only says "follicular lesion"; needs surgery | Yes — calcitonin IHC helps | Yes — usually obvious |
| Lymph node spread | Common (up to 50%) | Uncommon | Moderate | Extensive, early |
| Distant metastasis | Rare (lung) | Common — lung, bone, liver (haematogenous) | Liver, lung, bone | Lung, widespread |
| Route of spread | Lymphatics | Blood (haematogenous) | Both | Local invasion + blood |
| Functional status | Non-functional (cold nodule) | Usually cold; rarely hyperfunctional | Non-functional | Non-functional |
| Tumour marker | Thyroglobulin | Thyroglobulin | Calcitonin, CEA | None reliable |
| Radioiodine (RAI) sensitive? | Yes | Yes | No | No |
| TSH suppression therapy? | Yes | Yes | No | No |
| Surgery | Total thyroidectomy ± central neck dissection | Total thyroidectomy | Total thyroidectomy + central neck dissection | Palliative / debulking |
| Pre-op screening required | — | — | Phaeochromocytoma screen before surgery | — |
| 10-year survival | >95% | ~70–90% (minimally invasive); ~50% (widely invasive) | ~70–80% | <10% (most die within 1 year) |
| Post-op monitoring | Thyroglobulin + neck USS | Thyroglobulin + neck USS | Calcitonin + neck USS | CT imaging |
| Unique associations | Childhood radiation | Iodine-deficient regions | MEN2A/2B; screen family with RET testing | Previous thyroid cancer |
| Prognosis drivers | Age >40, extrathyroidal extension, distant mets | Degree of invasion (minimal vs. wide) | Distant mets, HVPG >20, RET mutation type | Always poor regardless of treatment |
| Type | Remember by |
|---|---|
| Papillary | "Paps smear the Lymph nodes" — spreads to Lymphatics; Psammoma bodies |
| Follicular | "Follicular needs the Blood" — haematogenous spread; FNAC can't diagnose it |
| Medullary | "Medullary Makes calcitonin + MEN" — the one with amyloid + RET |
| Anaplastic | "Anaplastic = Always fatal" — TP53, hard mass, rapid death |
Papillary Follicular Medullary Anaplastic
Origin: Follicular Follicular C cells Follicular
Spread: Lymph Blood Both Local+Blood
Marker: Tg Tg Calcitonin None
RAI: Yes Yes NO NO
Survive: Excellent Good Moderate Lethal
Mutate: BRAF RAS/PAX8 RET TP53
Dr Rashide's questions : 1. Anaplastic vs lymphoma 2. Follicular vs papillary 3. Medullary : Sporadic vs Familial 4. FNAC vs Tru-cut 5. Prognosis and tumour market of anaplastic, lymphoma, follicular, papillary, medullary CA
| Feature | Anaplastic Carcinoma | Primary Thyroid Lymphoma |
|---|---|---|
| Age | >60 years | >60 years |
| Sex | F > M | F > M |
| Background | Pre-existing PTC/follicular CA or goitre | Hashimoto's thyroiditis (40–80% of cases) |
| Risk increase | Prior well-differentiated thyroid CA | Hashimoto's → 60–80x increased lymphoma risk |
| Onset | Weeks | Weeks–months |
| Consistency | Rock hard, stony, fixed | Firm, "rubbery," may be less hard |
| Pain | Variable | Variable |
| B symptoms | Absent | Present — fever, night sweats, weight loss |
| Compressive symptoms | Dysphagia, hoarseness, stridor | Dysphagia, stridor |
| Cell type | Epithelial (follicular cell origin) | Lymphoid — usually diffuse large B-cell lymphoma (DLBCL) |
| Key mutation | TP53 loss | BCL-2 rearrangement, MYC |
| Histology | Pleomorphic/giant/spindle cells; no differentiation | Sheets of atypical lymphoid cells |
| IHC markers | CK+, thyroglobulin −, TTF-1 − | CD20+, CD3−, LCA+ |
| FNAC | Anaplastic cells — may be adequate | Lymphoid cells — but architecture needed |
| Preferred biopsy | Tru-cut / core needle | Tru-cut / core needle (FNAC often insufficient — need architecture) |
| Radioiodine | No | No |
| Treatment | Palliative (surgery/tracheostomy + RT ± chemo) | Chemotherapy (R-CHOP) + Radiotherapy — potentially CURABLE |
| Prognosis | Median survival <6 months; 1-yr survival <10% | Much better — 5-yr survival 50–70% with treatment |
Surgeon's pearl: If you see a rapidly enlarging thyroid mass in an elderly woman with Hashimoto's — think lymphoma first. It's treatable. Mistaking it for anaplastic and doing aggressive surgery is harmful.
| Feature | Papillary (PTC) | Follicular (FTC) |
|---|---|---|
| Frequency | ~85% | 5–15% |
| Age | 30–50 yrs | 40–60 yrs |
| Association | Radiation, Hashimoto's | Iodine deficiency |
| Key mutation | BRAF V600E (~80%), RET/PTC fusion | RAS, PAX8/PPARG fusion |
| Gross | Multifocal, may be bilateral | Usually solitary, encapsulated |
| Histology | Papillary fronds, Orphan Annie nuclei, nuclear grooves, psammoma bodies | Uniform follicles resembling normal thyroid |
| Psammoma bodies | Yes | No |
| Capsular invasion | Not a requirement for diagnosis | Required for diagnosis |
| Vascular invasion | Uncommon | Common — defines malignancy |
| FNAC diagnosis | Yes — nuclear features diagnostic | No — only "follicular lesion"; can't distinguish adenoma from carcinoma |
| Route of spread | Lymphatics → cervical LN (up to 50%) | Blood → lung, bone, liver |
| LN metastasis | Common | Rare |
| Distant mets | Uncommon | More common |
| RAI sensitivity | Yes | Yes |
| Prognosis | Excellent — >95% 10-yr survival | Good (minimally invasive) to moderate (widely invasive) |
| Tumour marker | Thyroglobulin | Thyroglobulin |
| Surgery | Total thyroidectomy ± neck dissection | Hemithyroidectomy (if follicular lesion on FNAC) → completion thyroidectomy if carcinoma confirmed |
Key distinction: PTC is diagnosed by nuclear features on FNAC. FTC can only be diagnosed on surgical histology by finding capsular or vascular invasion. This is why all "follicular lesions" on FNAC go to the theatre.
| Feature | Sporadic MTC | Familial MTC |
|---|---|---|
| Frequency | ~70% | ~30% |
| Inheritance | Acquired somatic mutation | Autosomal dominant |
| Gene | Somatic RET point mutation | Germline RET mutation |
| Age at presentation | 40s–50s (adults) | Younger — even 1st decade in MEN2B |
| Laterality | Unilateral, solitary | Bilateral + multifocal |
| C-cell hyperplasia | Absent | Present (precursor lesion in contralateral lobe) |
| Associated syndromes | None | MEN2A, MEN2B, Familial MTC (FMTC) |
| MEN2A components | — | MTC + Phaeochromocytoma + Hyperparathyroidism |
| MEN2B components | — | MTC + Phaeochromocytoma + Mucosal neuromas + Marfanoid habitus |
| Pre-op screening | Phaeochromocytoma screen | Mandatory phaeochromocytoma screen before any surgery |
| Family screening | Not needed | Genetic screening of all 1st-degree relatives (RET mutation testing) |
| Prophylactic thyroidectomy | Not applicable | Yes — offered to RET mutation carriers; timing based on mutation risk category |
| Prognosis | Better (localized) | Worse in MEN2B (most aggressive); FMTC has best prognosis |
| Marker | Calcitonin, CEA | Calcitonin, CEA |
High-yield: In any MTC patient — screen for phaeochromocytoma first. Operating on an undiagnosed phaeochromocytoma can precipitate a fatal hypertensive crisis on the table.
| Feature | FNAC (Fine Needle Aspiration Cytology) | Tru-cut (Core Needle Biopsy) |
|---|---|---|
| Needle size | 22–25G (fine) | 14–18G (large bore, cutting) |
| What you get | Individual cells (cytology) | Core of tissue (histology) |
| Anaesthesia | Local or none | Local anaesthesia |
| Architecture preserved? | No | Yes — intact tissue architecture |
| Capsular invasion visible? | No | Yes |
| IHC possible? | Limited | Yes — full panel possible |
| Speed | Fast, result in hours | Slower, 24–48 hrs |
| Pain/discomfort | Minimal | More |
| Complication risk | Very low | Low but higher than FNAC |
| Seeding risk | Very low | Slightly higher (theoretical) |
| Best for | PTC (nuclear features on cytology), benign cysts, initial triage | Lymphoma, anaplastic (need architecture + IHC), indeterminate FNAC |
| Cannot diagnose | Follicular carcinoma (needs capsular invasion), lymphoma (needs architecture) | — |
| Bethesda system | Applies to FNAC | Does not apply |
| Scenario | Preferred biopsy |
|---|---|
| Suspicious thyroid nodule — first line | FNAC |
| FNAC shows "follicular lesion" (Bethesda IV) | Surgery (hemithyroidectomy) |
| Rapidly enlarging mass — ? lymphoma / ? anaplastic | Tru-cut |
| Recurrent thyroid mass post-surgery | Tru-cut or FNAC (US-guided) |
| Metastatic neck node — unknown primary | Tru-cut |
| Cancer | Tumour Marker(s) | 5-year Survival | 10-year Survival | Prognostic Factors |
|---|---|---|---|---|
| Papillary | Thyroglobulin (Tg) | ~98% | >95% | Age >40, extrathyroidal extension, distant mets, BRAF V600E |
| Follicular | Thyroglobulin (Tg) | ~85–90% | ~70–90% (minimally invasive); ~50% (widely invasive) | Degree of vascular invasion, distant mets, age |
| Medullary | Calcitonin, CEA | ~75–80% | ~65–70% | Distant mets, RET mutation type, MEN2B worst |
| Anaplastic | None reliable (thyroglobulin −, calcitonin −) | <10% | ~0% | Median survival 4–6 months; essentially uniformly fatal |
| Lymphoma | LDH, Beta-2 microglobulin (not thyroid-specific) | ~50–70% (DLBCL) | Depends on stage/type | Stage, International Prognostic Index (IPI), DLBCL vs MALT (MALT has better prognosis) |
Anaplastic vs Lymphoma:
Both = rapid hard mass in elderly
Lymphoma → Hashimoto's background, B symptoms, CD20+, CURABLE with R-CHOP
Anaplastic → prior thyroid CA, TP53, CK+, always fatal
Papillary vs Follicular:
PTC → FNAC works, lymphatic spread, psammoma bodies, BRAF
FTC → FNAC can't diagnose, blood spread, needs capsular invasion, RAS/PAX8
Medullary Sporadic vs Familial:
Sporadic → unilateral, somatic RET, adults
Familial → bilateral/multifocal, germline RET, younger, MEN2 → SCREEN FAMILY
FNAC vs Tru-cut:
FNAC = cells only; good for PTC, first-line
Tru-cut = tissue architecture; needed for lymphoma, anaplastic, follicular adenoma vs CA
Markers:
PTC/FTC → Thyroglobulin
MTC → Calcitonin + CEA
Anaplastic → None
Lymphoma → LDH, Beta-2 microglobulin
Icsol
Choledocholethiasis 101
Thyroid ca 101